Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
Robert M Berman1, Michael E Thase2, Madhukar H Trivedi3, James A Hazel4, Sabrina Vogel Marler5, Robert D McQuade6, William Carson7, Ross A Baker8, Ronald N Marcus91Neuroscience Global Clinical Research Bristol-Myers Squibb, Wallingford, CT, USA; 2Department of Psychiatry, University of Pennsylvania...
Zapisane w:
| Główni autorzy: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Dove Medical Press
2011-05-01
|
| Seria: | Neuropsychiatric Disease and Treatment |
| Dostęp online: | http://www.dovepress.com/long-term-safety-and-tolerability-of-open-label-aripiprazole-augmentat-a7518 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|